biotech · Coronary Artery Disease · Bronchopulmonary Dysplasia · ASBP
Aspire Biopharma Holdings
Aspire Biopharma Holdings trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Humacao, USA HQ
2019 Founded
Public company Type
ASBP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Humacao, USA
- Founded
- 2019
- Programs
- 8
- Drugs
- 8
- Patents
- 1
Aspire Biopharma Holdings clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to Aspire Biopharma Holdings programs — each row shows trial ID, program name, phase, status, and indication.
Aspire Biopharma Holdings trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Aspire Biopharma Holdings.
-
Retinol — Phase 2
Clinical update -
Regadenoson — Approved
Clinical update -
Pulse Sequence — Approved
Clinical update -
ACT-20-MSC — Phase 2
Clinical update -
AdreView — Approved
Clinical update -
Myocardial perfusion imaging — Approved
Clinical update -
Beet It Sport Shot — Unknown
Clinical update -
Nutritional Supplement — Unknown
Clinical update